Order Article Reprints

Oyinloye BE, Shamaki DE, Agbebi EA, Onikanni SA, Ubah CS, Aruleba RT, Dao TNP, Owolabi OV, Idowu OT, Mathenjwa-Goqo MS, et al. In Silico Comparison of Bioactive Compounds Characterized from Azadirachta indica with an FDA-Approved Drug against Schistosomal Agents: New Insight into Schistosomiasis Treatment. Molecules. 2024; 29(9):1909. https://doi.org/10.3390/molecules29091909

Oyinloye, Babatunji Emmanuel, David Ezekiel Shamaki, Emmanuel Ayodeji Agbebi, Sunday Amos Onikanni, Chukwudi Sunday Ubah, Raphael Taiwo Aruleba, Tran Nhat Phong Dao, Olutunmise Victoria Owolabi, Olajumoke Tolulope Idowu, Makhosazana Siduduzile Mathenjwa-Goqo, and et al. 2024. "In Silico Comparison of Bioactive Compounds Characterized from Azadirachta indica with an FDA-Approved Drug against Schistosomal Agents: New Insight into Schistosomiasis Treatment" Molecules 29, no. 9: 1909. https://doi.org/10.3390/molecules29091909

Oyinloye, B. E., Shamaki, D. E., Agbebi, E. A., Onikanni, S. A., Ubah, C. S., Aruleba, R. T., Dao, T. N. P., Owolabi, O. V., Idowu, O. T., Mathenjwa-Goqo, M. S., Esan, D. T., Ajiboye, B. O., & Omotuyi, O. I. (2024). In Silico Comparison of Bioactive Compounds Characterized from Azadirachta indica with an FDA-Approved Drug against Schistosomal Agents: New Insight into Schistosomiasis Treatment. Molecules, 29(9), 1909. https://doi.org/10.3390/molecules29091909